Prevalence of β-lactamase and antibiotic-resistant Pseudomonas aeruginosa in the Arab region

被引:20
作者
Nasser, Mahfouz [1 ]
Gayen, Samarpita [1 ]
Kharat, Arun S. [1 ,2 ]
机构
[1] Dr Babasaheb Ambedkar Marathwada Univ, Dept Biotechnol, Subcampus Osmanabad, Shingoli, MS, India
[2] Jawaharlal Nehru Univ, Sch Life Sci, Lab Appl Microbiol, New Delhi, India
关键词
Molecular; beta-lactamase; Pseudomonas aeruginosa; Arab region; EXTENDED-SPECTRUM; ACINETOBACTER-BAUMANNII; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; CARBAPENEMASE; EMERGENCE; OUTBREAK; VIM-2; ENTEROBACTERIACEAE; STRAINS;
D O I
10.1016/j.jgar.2020.01.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Several studies in the Arab region have recognised the rate of nosocomial infections caused by Pseudomonas aeruginosa (P. aeruginosa), which produce p-lactamase, and identified their emergence and prevalence in the region. This article reviewed molecular studies on these beta-lactamase-producing P. aeruginosa during 2010-2018 in several countries of the Arab region in order to analyse the trend of rising prevalence of disease causing drug-resistant P. aeruginosa in the Arab region. Methods: Data from selected clinical studies during 2010-2018 on beta-lactamase-producing P. aeruginosa in the Arab region were obtained from reliable scientific databases for analysis and evaluation. Results: Significant changes were found in resistance of P. aeruginosa towards certain antibiotics of the plactam class. There was an increasing trend in the occurrence of resistance genes in beta-lactamase-producing P. aeruginosa. Conclusion: This review showed that there is an increasing prevalence of beta-lactamase-producing P. aeruginosa in some countries in the Arab region. This is a major cause of concern as this implies that more and more instances of multidrug resistance are emerging in this area. This leads to an overall negative impact on health concerns and amounts to increasing difficulty in combating disease. It is recommended that awareness about antibiotic use and abuse be made a priority and measures to curb unchecked use of prescription antibiotics be put into place. Effective screening methods to detect cases of resistance at their onset may be developed. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
引用
收藏
页码:152 / 160
页数:9
相关论文
共 41 条
[1]   Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa in a Healthcare Setting in Alexandria, Egypt [J].
Abaza, Amani F. ;
El Shazly, Soraya A. ;
Selim, Heba S. A. ;
Aly, Gehan S. A. .
POLISH JOURNAL OF MICROBIOLOGY, 2017, 66 (03) :297-308
[2]  
Abdalhamid B., 2016, New Microbes and New Infections, V10, P77, DOI 10.1016/j.nmni.2016.01.014
[3]   Emergence of VIM-2 and IMP-15 Carbapenemases and Inactivation of oprD Gene in Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Lebanon [J].
Al Bayssari, Charbel ;
Diene, Seydina M. ;
Loucif, Lotfi ;
Gupta, Sushim Kumar ;
Dabboussi, Fouad ;
Mallat, Hassan ;
Hamze, Monzer ;
Rolain, Jean-Marc .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (08) :4966-4970
[4]   Antimicrobial resistance and putative virulence genes of Pseudomonas aeruginosa isolates from patients with respiratory tract infection [J].
Al Dawodeyah, Heba Y. ;
Obeidat, Nathir ;
Abu-Qatouseh, Luay F. ;
Shehabi, Asem A. .
GERMS, 2018, 8 (01) :31-40
[5]   Diversity of Molecular Mechanisms Conferring Carbapenem Resistance to Pseudomonas aeruginosa Isolates from Saudi Arabia [J].
Al-Agamy, Mohamed H. ;
Jeannot, Katy ;
El-Mahdy, Taghrid S. ;
Samaha, Hassan A. ;
Shibl, Atef M. ;
Plesiat, Patrick ;
Courvalin, Patrice .
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2016, 2016
[6]   Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia [J].
Al-Agamy, Mohamed H. ;
Shibl, Atef M. ;
Tawfik, Abdulkader F. ;
Elkhizzi, Noura A. ;
Livermore, David M. .
JOURNAL OF CHEMOTHERAPY, 2012, 24 (02) :97-100
[7]  
Al-Charrakh Alaa H, 2016, Acta Med Iran, V54, P107
[8]  
[Anonymous], 2017, GLOBAL ANTIMICROBIAL
[9]  
[Anonymous], 2014, ISRN MICROBIOL, DOI DOI 10.1155/2014/941507
[10]  
[Anonymous], 2015, Surveillance Report